Search

everythinglearnresearchcommunity

for

Search:↓

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

A cancer patient's hair became permanently curly after treatment with nivolumab.

The Hair Check tool can measure hair loss, but patients' own reports are more reliable for assessing hair loss during chemotherapy.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Most patients' skin darkening after sclerotherapy fades on its own within 6-24 months.

Afatinib often causes skin problems that need proactive management.

Acne keloidalis is a chronic skin condition on the back of the neck in young black men, needing surgery for severe cases.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Mild oxidative stress can prevent hair loss from chemotherapy.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Low-dose chemotherapy is safer, more effective, and cost-effective than surgery for treating bone lesions in children.

Regenerative medicine may help reduce radiotherapy side effects like skin cancer, fibrosis, pain, and hair loss.

Chemotherapy with docetaxel and cisplatin can cause severe low potassium, requiring careful monitoring and treatment.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Human dental pulp stem cell-conditioned medium, especially from hypoxic conditions, may help treat chemotherapy-induced hair loss and does not increase cancer risk.

Topical imiquimod use for treating a cervical lesion might cause delayed hair loss.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

A group has developed therapies that show promise for treating cancer and various other conditions.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Tempol is safe and may prevent hair loss from brain radiotherapy.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Iron deficiency may contribute to hair loss.

Syphilis is becoming more common and remains a major health problem due to challenges in prevention and treatment.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.